The goal of our admissions process is to set you up for success by making sure you are matched up with the right program.
True to the Bootcamp monicker, our boot camps programs are tough. Successful completion requires a degree of mental toughness, a growth mindset, being able to learn from hundreds of mistakes, and working as a team to grow together.
Oops! We could not locate your form.
BLX-3030 is an investigational oral CDK9 inhibitor that shows excellent anti-tumor and other on-target CDK9-driven activity in preclinical models. Inhibiting CDK9 downregulates certain transcription factors, including C-Myc and N-Myc, which are required for tumor resistance and are drivers of both mCRPC and NEPC.